Estimation of Incubation Period for Oropouche Virus Disease among Travel-Associated Cases, 2024–2025

Determining the incubation period of Oropouche virus disease can inform clinical and public health practice. We analyzed data from 97 travel-associated cases identified by the Centers for Disease Control and Prevention (n = 74) or the GeoSentinel Network (n = 13) and 10 cases from published literature. Using log-normal interval-censored survival analysis, we estimated the median incubation period to be 3.2 (95% CI 2.5-3.9) days. Symptoms developed by 1.1 (95% CI 0.6-1.5) days for 5% of patients, 9.7 (95% CI 6.9-12.5) days for 95% of patients, and 15.4 (95% CI 9.6-21.3) days for 99% of patients. The estimated incubation period range of 1-10 days can be used to assess timing and potential source of exposure in patients with Oropouche symptoms. For patients with symptom onset >2 weeks after return from travel, clinicians and public health responders should consider the possibility of local vectorborne transmission or alternative modes of transmission.

Authors

Publication Details

Journal
Emerging infectious diseases
Published
2025-06-24
DOI
https://doi.org/10.3201/eid3107.250468
Citations
8
Primary Topic
Viral Infections and Vectors
Type
article
Field-Weighted Citation Impact
11.17
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Estimation of Incubation Period for Oropouche Virus Disease among Travel-Associated Cases, 2024–2025

Concetta Castilletti, Daniel Jacobs, Ralph Huits, Sarah Anne J. Guagliardo et al.
8 citations
Emerging infectious diseases
Viral Infections and Vectors
11.17
article

Estimation of Incubation Period for Oropouche Virus Disease among Travel-Associated Cases, 2024–2025

Concetta Castilletti, Daniel Jacobs, Ralph Huits, Sarah Anne J. Guagliardo, Kevin O’Laughlin, Stacey W. Martin, J. Erin Staples, Carolyn V. Gould, Rebekah Sutter
article en
8 citations

Abstract

Determining the incubation period of Oropouche virus disease can inform clinical and public health practice. We analyzed data from 97 travel-associated cases identified by the Centers for Disease Control and Prevention (n = 74) or the GeoSentinel Network (n = 13) and 10 cases from published literature. Using log-normal interval-censored survival analysis, we estimated the median incubation period to be 3.2 (95% CI 2.5-3.9) days. Symptoms developed by 1.1 (95% CI 0.6-1.5) days for 5% of patients, 9.7 (95% CI 6.9-12.5) days for 95% of patients, and 15.4 (95% CI 9.6-21.3) days for 99% of patients. The estimated incubation period range of 1-10 days can be used to assess timing and potential source of exposure in patients with Oropouche symptoms. For patients with symptom onset >2 weeks after return from travel, clinicians and public health responders should consider the possibility of local vectorborne transmission or alternative modes of transmission.

Emerging infectious diseasesVol. 31(7)
Good health and well-being
Openalex Percentile: Top 1%
Viral Infections and Vectors
11.17
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.